Regulatory considerations on the enrollment of older adults in oncology clinical trials

被引：3
|
作者：
Raimi-Abraham, Bahijja Tolulope [1 ,4 ]
de Orbe Izquierdo, Maria Silvia [2 ,4 ]
Collignon, Olivier [3 ,4 ]
Cerreta, Frahcesca [4 ]
机构：
[1] UCL, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England
[2] Hosp Univ Ramon & Cajal, Fdn Invest Biomed, IRYCIS, Ctra Colmenar Viejo,Km 9,100, Madrid 28034, Spain
[3] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, 1A Rue Thomas Edison, L-1445 Strassen, Luxembourg
[4] European Med Agcy, 30 Churchill Pl, London E14 5E, England
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2017年 / 8卷 / 03期
基金：
英国工程与自然科学研究理事会;
关键词：
CANCER; PARTICIPATION;
D O I：
10.1016/j.jgo.2017.02.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：151 / 153
页数：3
相关论文
共 50 条
  • [1] Enrollment of older adults on oncology trials: An FDA perspective
    Singh, Harpreet
    Beaver, Julia A.
    Kim, Geoffrey
    Pazdur, Richard
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (03) : 149 - 150
  • [2] Enrollment of older adults in clinical trials for oncology indications, 2010-2020: An evaluation by the FDA
    Yang, Felice
    Lerro, Catherine C.
    Feng, Zhou
    Akinboro, Oladimeji
    Curley, Richard
    Dilawari, Asma Ali
    Fiero, Mallorie
    Huang, Yue
    Ison, Gwynn
    Kanapuru, Bindu
    Leong, Ruby
    Liu, Wei
    Patel, Timil
    Suzman, Daniel L.
    Kluetz, Paul Gustav
    Singh, Harpreet
    Rivera, Donna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Evaluation of Enrollment in Oncology Phase I Clinical Trials
    van der Biessen, A. J.
    Cranendonk, M. A.
    van der Holt, B.
    Verweij, J.
    de Jonge, M. J. A.
    Mathijssen, R. H. J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S161 - S161
  • [4] EXAMINING MINORITY ENROLLMENT IN CLINICAL TRIALS IN UROLOGIC ONCOLOGY
    Owens-Walton, Jeunice
    Williams, Cheyenne
    Rompre-Brodeur, Alexis
    Pinto, Peter
    Ball, Mark W.
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E749 - E749
  • [5] Barriers to enrollment in clinical trials in gynecologic oncology.
    McMinn, Erin
    Smith, Anna Jo Bodurtha
    Arasappan, Dhivya
    Koelper, Nathanael
    Simpkins, Fiona
    Howell, Elizabeth A.
    Ko, Emily Meichun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials
    Habr, Dany
    McRoy, Lynn
    Papadimitrakopoulou, Vassiliki A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (11) : 1460 - 1464
  • [7] Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials
    van der Biessen, Diane A. J.
    Cranendonk, Merlijn A.
    Schiavon, Gaia
    van der Holt, Bronno
    Wiemer, Erik A. C.
    Eskens, Ferry A. L. M.
    Verweij, Jaap
    de Jonge, Maja J. A.
    Mathijssen, Ron H. J.
    [J]. ONCOLOGIST, 2013, 18 (03): : 323 - 329
  • [8] Physician-reported reasons for non-enrollment of older adults in cancer clinical trials
    Lackman, Miki
    Vickers, Michael M.
    Hsu, Tina
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (01) : 31 - 36
  • [9] Clinical trials networks and enrollment of historically underrepresented populations in medical oncology trials
    Berkowitz, J. L.
    Fernandez, A.
    Dichmann, R. A.
    Kennedy, K. A.
    DiCarlo, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Regulatory and clinical considerations for biosimilar oncology drugs
    Bennett, Charles L.
    Chen, Brian
    Hermanson, Terhi
    Wyatt, Michael D.
    Schulz, Richard M.
    Georgantopoulos, Peter
    Kessler, Samuel
    Raisch, Dennis W.
    Qureshi, Zaina P.
    Lu, Z. Kevin
    Love, Bryan L.
    Noxon, Virginia
    Bobolts, Laura
    Armitage, Melissa
    Bian, John
    Ray, Paul
    Ablin, Richard J.
    Hrushesky, William J.
    Macdougall, Iain C.
    Sartor, Oliver
    Armitage, James O.
    [J]. LANCET ONCOLOGY, 2014, 15 (13): : E594 - E605
12345